Abbott Laboratories Inc. is unloading its ophthalmic business to Johnson & Johnson for $4.325bn.
The sale of Abbott Medical Optics unit comes as Abbott is overhauling its medtech portfolio. The firm has repeatedly told...
J&J Buys Abbott's Ophthalmics Business For $4bn-Plus
The move to sell Abbott Medical Optics unit comes in the midst of a significant portfolio overhaul by Abbott. The deal will put J&J in the ophthalmic surgery business.